Tests Selank and MIF (a shorter tuftsin derivative) in a rat model of intracerebral hemorrhage (hemorrhagic stroke). Selank (300 μg/kg/day, i.p.) reduced neurological deficits and brain edema on MRI compared to controls. Suggests Selank has neuroprotective properties relevant to hemorrhagic stroke recovery, extending its therapeutic potential beyond anxiety disorders.
Skvortsova, V I; Tvorogova, T V; Dubina, A I; Burenchev, D V; Gubskiĭ, L V; Stakhovskaia, L V; Povarova, O V